What is the management of resected cholangiocarcinoma in terms of intra- and postoperative status of tumor margins and lymph nodes? A current view

Expert Rev Gastroenterol Hepatol. 2022 Nov-Dec;16(11-12):1019-1022. doi: 10.1080/17474124.2022.2155633. Epub 2022 Dec 13.

Authors

Konstantin Schlick^{1

2}, Bettina Neumayer^{2

3}, Daniel Neureiter^{2

3}

Affiliations

¹ Oncologic Center, Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Paracelsus Medical University, Salzburg, Austria.
² Cancer Cluster Salzburg, Cancer Cluster.
³ Institute of Pathology, University Clinics Salzburg, Paracelsus Medical University, Salzburg, Austria.

PMID: 36472068
DOI: 10.1080/17474124.2022.2155633

No abstract available

Keywords: adjuvant treatment strategy; biliary tract cancer; cholangiocarcinoma; intra-operative re-operation; margin status; nodal status.

Publication types

Editorial
Comment

MeSH terms

Bile Duct Neoplasms* / pathology
Bile Duct Neoplasms* / surgery
Bile Ducts, Intrahepatic / pathology
Cholangiocarcinoma* / pathology
Cholangiocarcinoma* / surgery
Humans
Lymph Nodes / pathology
Lymph Nodes / surgery
Retrospective Studies